Related Experiment Video
Updated: Aug 6, 2026
13:21
Graphene Coatings for Biomedical Implants
Published on: March 1, 2013
Exfoliation in Endotoxin-Free Albumin Generates Pristine Graphene with Reduced Inflammatory Properties
Filipa Lebre1,2,3, Damien Hanlon2,3,4, John B Boland2,3,4
1Adjuvant Research Group School of Biochemistry and Immunology Trinity Biomedical Sciences Institute Trinity College Dublin Dublin 2 D02 PN40 Ireland.
Advanced Biosystems
|July 17, 2026
Summary
Researchers developed endotoxin-free pristine graphene (EF-Gr) using a novel method. This biomaterial shows low toxicity and minimal immune response, paving the way for safer graphene applications in medicine.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Immunology
Background:
- Graphene-based materials offer unique properties for medical applications.
- Residual endotoxins in biomaterials can cause harmful inflammatory and immunomodulatory effects, hindering clinical use.
- Developing contaminant-free graphene is crucial for accurate assessment of its biomedical potential.
Purpose of the Study:
- To develop an endotoxin-free pristine graphene (EF-Gr) using a liquid exfoliation method.
- To compare the toxicity and immunogenicity of EF-Gr with conventional graphene preparations.
- To evaluate the potential of EF-Gr for biomedical applications by mitigating confounding contaminant effects.
Main Methods:
- Liquid exfoliation of graphene using bovine serum albumin (BSA).
- Preparation of endotoxin-free graphene (EF-Gr) and comparison with conventional BSA-exfoliated graphene (C-Gr) and sodium cholate-exfoliated graphene (SC-Gr).
- In vitro assessment of cytotoxicity and immune response in dendritic cells (DCs) and macrophages, including cytokine secretion and costimulatory molecule expression.
- In vivo evaluation of inflammatory response in mice.
Main Results:
- Protein-exfoliated graphene, particularly EF-Gr, exhibited low toxicity compared to SC-Gr.
- EF-Gr did not induce significant cytokine secretion or increase costimulatory molecule expression in DCs and macrophages.
- EF-Gr retained the ability to activate the NLRP3 inflammasome in TLR-primed DCs.
- In vivo inflammatory response to EF-Gr was comparable to the vaccine adjuvant alum.
- The study suggests that previous immunostimulatory effects of graphene may be due to contaminants.
Conclusions:
- A feasible method for producing endotoxin-free pristine graphene (EF-Gr) was established.
- EF-Gr demonstrates low toxicity and reduced immunogenicity, making it a promising candidate for biomedical applications.
- This work enables a clearer understanding of pristine graphene's inherent properties for medical use, free from contaminant interference.
